Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.21
ratio cours/chiffre d'affaires
0.24
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4356 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.09 USD | +3.92% | -17.37% | +41.96% | -37.79% | 37.98 M USD | ||
| 4366 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.54 USD | +1.32% | -10.98% | +35.09% | -62.25% | 36.98 M USD | ||
| 4387 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.06 USD | -1.90% | -20.16% | -54.42% | -78.33% | 34.88 M USD | ||
| 4398 | LITS Lite Strategy, Inc. - Common Stock | 0.99 USD | 0.00% | -5.71% | +2.06% | -66.78% | 33.68 M USD |